Hansen Gwenn
CIK 0001817160
Chief Scientific Officer
Filings
23
Latest Apr 30, 2026
Issuers covered
1
Showing
23 of 23
Page 1
Track record
18 of 18 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 18 | 61% | +2.3% | +6.1% | +37.0% | -54.6% |
| 90 days | 17 | 41% | -3.8% | -1.1% | +51.1% | -76.8% |
| 180 days | 15 | 53% | -16.0% | +4.6% | +53.4% | -166.0% |
| 365 days | 13 | 62% | -31.6% | +17.5% | +63.4% | -330.6% |
Issuers
Companies where Hansen Gwenn has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| NRIX | Nurix Therapeutics, Inc. | 23 | Apr 30, 2026 |
All filings
23 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|